Cargando…
Fenoldopam use in a burn intensive care unit: a retrospective study
BACKGROUND: Fenoldopam mesylate is a highly selective dopamine-1 receptor agonist approved for the treatment of hypertensive emergencies that may have a role at low doses in preserving renal function in those at high risk for or with acute kidney injury (AKI). There is no data on low-dose fenoldopam...
Autores principales: | Simmons, John W, Chung, Kevin K, Renz, Evan M, White, Christopher E, Cotant, Casey L, Tilley, Molly A, Hardin, Mark O, Jones, John A, Blackbourne, Lorne H, Wolf, Steven E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904291/ https://www.ncbi.nlm.nih.gov/pubmed/20576149 http://dx.doi.org/10.1186/1471-2253-10-9 |
Ejemplares similares
-
Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study
por: Chung, Kevin K, et al.
Publicado: (2009) -
Renal protection in the ICU: role of fenoldopam
por: Bertini, P, et al.
Publicado: (2008) -
Periferic intravenous infusion of fenoldopam through an elastomeric pump
por: Quaranta, T, et al.
Publicado: (2009) -
Fenoldopam Increases Urine Output in Oliguric Critically Ill Surgical Patients
por: Cagliani, Joaquin A, et al.
Publicado: (2021) -
Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients
por: Hammer, Gregory B, et al.
Publicado: (2008)